Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Non Small Cell Lung Cancer

Cancer Research UK and Biotecnol to trial new immuno-oncology treatment for advanced tumours

Cancer Research UK and Biotecnol Limited will trial an experimental immuno-oncology treatment for some patients with advanced tumours.

Two clinical trials show promise with different targeted drugs for lung cancer

Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available.

Targeted drug delays relapse of intermediate-stage lung cancer

A drug holds lung cancer at bay longer after surgery than standard chemotherapy, according to unpublished results of a new trial in China.

Tracking unstable chromosomes helps predict lung cancer’s return

The first findings from the Cancer Research UK-funded TRACERx* lung cancer study show how tracking tumour evolution can help predict relapse.

Immunotherapy drug extends lives of advanced lung cancer patients

A drug that ‘reinvigorates the immune system’ can extend the lives of lung cancer patients with reduced side effects.

Achilles Therapeutics launched with funds of £13.2 million to develop immunotherapies for cancer

Syncona LLP and Cancer Research Technology (CRT) announce the formation of Achilles Therapeutics Ltd today.

Lung cancer patients whose tumour has spread to the brain could be spared radiotherapy

Patients with non-small cell lung cancer which has spread to the brain could be spared whole brain radiotherapy.

Scientists discover drug combination slows lung cancer cell growth

Scientists have shown that a drug combination slows cancer cell growth in a type of non-small cell lung cancer when tested in the lab.

Doubling-up on cancer immunotherapy shows promise, but side effects still a challenge

A combination of two immunotherapy drugs outperformed a single drug treatment in patients with a type of advanced lung cancer.

US hospital commits to lung cancer ‘liquid biopsy’

Analysing tumour DNA in blood samples could help doctors offer ‘targeted’ treatments best suited to a patient’s lung cancer.

Pages